Differentiation of Acinetobacter Genomic Species 13BJ/14TU from Acinetobacter haemolyticus by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F15%3A00011029" target="_blank" >RIV/75010330:_____/15:00011029 - isvavai.cz</a>

Výsledek na webu

<a href="http://jcm.asm.org/content/53/10/3384" target="_blank" >http://jcm.asm.org/content/53/10/3384</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1128/JCM.03468-14" target="_blank" >10.1128/JCM.03468-14</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Differentiation of Acinetobacter Genomic Species 13BJ/14TU from Acinetobacter haemolyticus by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)

Popis výsledku v původním jazyce

Acinetobacter genomic species 13BJ and genomic species 14TU were delineated independently in 1989 based on DNA-DNA hybridization among proteolytic strains of human origin. Later studies suggested that these two taxa were congruent with each other at thespecies level and represented a distinct phylogroup within the hemolytic-proteolytic clade of the genus Acinetobacter. Reports from different countries showed that strains of Acinetobacter genomic species 13BJ/14TU were found in clinical specimens at a frequency similar to or even higher than that of another hemolytic and proteolytic species, Acinetobacter haemolyticus). It has also been noted that strains of Acinetobacter genomic species 13BJ/14TU are intrinsically resistant to polymyxins, which further underpins the clinical relevance of this taxon.

Název v anglickém jazyce

Differentiation of Acinetobacter Genomic Species 13BJ/14TU from Acinetobacter haemolyticus by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)

Popis výsledku anglicky

Acinetobacter genomic species 13BJ and genomic species 14TU were delineated independently in 1989 based on DNA-DNA hybridization among proteolytic strains of human origin. Later studies suggested that these two taxa were congruent with each other at thespecies level and represented a distinct phylogroup within the hemolytic-proteolytic clade of the genus Acinetobacter. Reports from different countries showed that strains of Acinetobacter genomic species 13BJ/14TU were found in clinical specimens at a frequency similar to or even higher than that of another hemolytic and proteolytic species, Acinetobacter haemolyticus). It has also been noted that strains of Acinetobacter genomic species 13BJ/14TU are intrinsically resistant to polymyxins, which further underpins the clinical relevance of this taxon.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

EE - Mikrobiologie, virologie

OECD FORD obor

—

Projekt

<a href="/cs/project/GA13-26693S" target="_blank" >GA13-26693S: Genetická diverzita a fylogeneze rodu Acinetobacter v přírodních ekosystémech.</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Clinical Microbiology

ISSN

0095-1137

e-ISSN

—

Svazek periodika

53

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

3

Strana od-do

3384-3386

Kód UT WoS článku

000365625300044

EID výsledku v databázi Scopus

—